戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 fect of season on serum calcidiol but not on serum parathyroid hormone.
2 ic characteristics, dietary intakes, fasting serum parathyroid hormone, 25-hydroxyvitamin D [25(OH)D]
3                                 Increases in serum parathyroid hormone accompanied skeletal healing,
4                   Radioimmunoassays measured serum parathyroid hormone and 25-hydroxyvitamin D.
5  significant relationship between increasing serum parathyroid hormone and a positive MIBI scan.
6 yroid hormone secretion in vitro to decrease serum parathyroid hormone and calcium concentrations in
7                                              Serum parathyroid hormone and calcium were measured repe
8  serum albumin and inversely associated with serum parathyroid hormone and ferritin.
9          The calcimimetic drug R-568 reduces serum parathyroid hormone and ionized calcium concentrat
10 e effect of dietary calcium and vitamin D on serum parathyroid hormone and vitamin D metabolites was
11 s, osteomalacia, hypophosphatemia, increased serum parathyroid hormone, and increased levels of the p
12                                          The serum parathyroid hormone concentration was inversely co
13                                     The mean serum parathyroid hormone concentration, which was 77+/-
14 eficiency rickets, bone mineral content, and serum parathyroid hormone concentration.
15 crease closely following the decrease in the serum parathyroid hormone concentration.
16                                       Higher serum parathyroid hormone concentrations showed a signif
17                                     Further, serum parathyroid hormone concentrations were significan
18 um (ie, increased urinary calcium, decreased serum parathyroid hormone, decreased bone resorption bio
19                            Concentrations of serum parathyroid hormone in February-March were signifi
20 er, multiply by 0.25; P = .15), preoperative serum parathyroid hormone level (mean [SD], 114.5 [56.8]
21  if tolerated) or nonparicalcitol therapy on serum parathyroid hormone levels (primary outcome), mine
22 tive vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in pati
23  (RR 1.07 per 10 mg(2)/dl(2); P < 0.005) and serum parathyroid hormone levels greater than 495 pg/ml
24                            However, very low serum parathyroid hormone levels have been associated wi
25  with baseline, median (interquartile range) serum parathyroid hormone levels significantly declined
26  4.4-kb deletion of STX16 and who had normal serum parathyroid hormone levels until the age of 21 mo.
27 vels were performed in only 18% of patients, serum parathyroid hormone levels were obtained in only 1
28 ifested by larger parathyroid glands, higher serum parathyroid hormone levels, much lower bone minera
29 IRP technique without routine intraoperative serum parathyroid hormone measurement resulted in an exc
30  in 683 patients receiving hemodialysis with serum parathyroid hormone (PTH) concentrations higher th
31 he intravenous calcimimetic etelcalcetide on serum parathyroid hormone (PTH) concentrations in patien
32 tions in blood ionized calcium (iCa(2+)) and serum parathyroid hormone (PTH) concentrations were also
33  and Cdc73(+/-) mice also had increased mean serum parathyroid hormone (PTH) concentrations.
34 fat oxidation, potentially via regulation of serum parathyroid hormone (PTH) concentrations.
35 bly, the PT-Dicer(-/-) mice did not increase serum parathyroid hormone (PTH) in response to acute hyp
36 parathyroidism is characterized by increased serum parathyroid hormone (PTH) level and parathyroid ce
37 al insufficiency is associated with elevated serum parathyroid hormone (PTH) levels (2 degrees HPT),
38                                              Serum parathyroid hormone (PTH) levels were elevated in
39 calcemia, anti-KRN23 antibodies, or elevated serum parathyroid hormone (PTH) or creatinine.
40                      CLA treatment increased serum parathyroid hormone (PTH) significantly (p=0.0172)
41          Body weight, bone turnover markers, serum parathyroid hormone (PTH), and dietary intake were
42 H)D] concentration >/=30 ng/mL) and decrease serum parathyroid hormone (PTH).
43 ntration below which there is an increase in serum parathyroid hormone (PTH).
44 used a sensitive radioimmunoassay to measure serum parathyroid hormone-related peptide (PTHrP) and a
45 cluded concentrations of serum 1,25(OH)(2)D, serum parathyroid hormone, serum creatinine, and serum e
46 -induced increases (P <0.01) in postprandial serum parathyroid hormone suppression.
47 D is more important than calcium in reducing serum parathyroid hormone, the source of dietary calcium
48                                              Serum parathyroid hormone was inversely correlated with
49 the relationship between scan positivity and serum parathyroid hormone was weaker.
50 .001) and the regression predicted that mean serum parathyroid hormone would be reduced in the elderl

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。